An analyst earlier this month took aim at what’s behind a big run-up in shares of Irvine medical device maker Edwards Lifesciences Corp.: a new type of heart valve that doesn’t require major surgery.

Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the agency’s first in this type of implant that takes a potentiall | The ...

Irvine heart valve maker Edwards Lifesciences Corp. has entered a critical phase in the development of a product it sees playing a key role in future heart surgeries. A team of Michigan cardiac ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

IRVINE, Calif., Oct. 15, 2015 -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug ...

NEWBURY, England--(BUSINESS WIRE)--Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic ...

IRVINE, Calif., Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received CE ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

Edwards Lifesciences is buying Valtech Cardio Ltd., which has developed the Cardioband System for transcatheter mitral and tricuspid valve repair. Valtech's Cardioband System is designed for minimally ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.

Medtronic scored a badly needed point in its heart valve struggles with rival Edwards Lifesciences when the European Patent Office (EPO; The Hague) ruled that Edwards' so-called Spenser patent was ...

IRVINE, Calif., March 31, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a ...